Diabetic Retinopathy Market, Global Outlook and Forecast 2023-2028

Report ID: 1140480 | Published Date: Jan 2025 | No. of Page: 62 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 Diabetic Retinopathy Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Diabetic Retinopathy Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Diabetic Retinopathy Overall Market Size
    2.1 Global Diabetic Retinopathy Market Size: 2021 VS 2028
    2.2 Global Diabetic Retinopathy Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Diabetic Retinopathy Players in Global Market
    3.2 Top Global Diabetic Retinopathy Companies Ranked by Revenue
    3.3 Global Diabetic Retinopathy Revenue by Companies
    3.4 Top 3 and Top 5 Diabetic Retinopathy Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Diabetic Retinopathy Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Diabetic Retinopathy Players in Global Market
        3.6.1 List of Global Tier 1 Diabetic Retinopathy Companies
        3.6.2 List of Global Tier 2 and Tier 3 Diabetic Retinopathy Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Diabetic Retinopathy Market Size Markets, 2021 & 2028
        4.1.2 Laser Surgery
        4.1.3 Injection of Corticosteroids
        4.1.4 Anti-VEGF Drugs
        4.1.5 Vitrectomy
    4.2 By Type - Global Diabetic Retinopathy Revenue & Forecasts
        4.2.1 By Type - Global Diabetic Retinopathy Revenue, 2017-2022
        4.2.2 By Type - Global Diabetic Retinopathy Revenue, 2023-2028
        4.2.3 By Type - Global Diabetic Retinopathy Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Diabetic Retinopathy Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Clinics
        5.1.4 Others
    5.2 By Application - Global Diabetic Retinopathy Revenue & Forecasts
        5.2.1 By Application - Global Diabetic Retinopathy Revenue, 2017-2022
        5.2.2 By Application - Global Diabetic Retinopathy Revenue, 2023-2028
        5.2.3 By Application - Global Diabetic Retinopathy Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Diabetic Retinopathy Market Size, 2021 & 2028
    6.2 By Region - Global Diabetic Retinopathy Revenue & Forecasts
        6.2.1 By Region - Global Diabetic Retinopathy Revenue, 2017-2022
        6.2.2 By Region - Global Diabetic Retinopathy Revenue, 2023-2028
        6.2.3 By Region - Global Diabetic Retinopathy Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Diabetic Retinopathy Revenue, 2017-2028
        6.3.2 US Diabetic Retinopathy Market Size, 2017-2028
        6.3.3 Canada Diabetic Retinopathy Market Size, 2017-2028
        6.3.4 Mexico Diabetic Retinopathy Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Diabetic Retinopathy Revenue, 2017-2028
        6.4.2 Germany Diabetic Retinopathy Market Size, 2017-2028
        6.4.3 France Diabetic Retinopathy Market Size, 2017-2028
        6.4.4 U.K. Diabetic Retinopathy Market Size, 2017-2028
        6.4.5 Italy Diabetic Retinopathy Market Size, 2017-2028
        6.4.6 Russia Diabetic Retinopathy Market Size, 2017-2028
        6.4.7 Nordic Countries Diabetic Retinopathy Market Size, 2017-2028
        6.4.8 Benelux Diabetic Retinopathy Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Diabetic Retinopathy Revenue, 2017-2028
        6.5.2 China Diabetic Retinopathy Market Size, 2017-2028
        6.5.3 Japan Diabetic Retinopathy Market Size, 2017-2028
        6.5.4 South Korea Diabetic Retinopathy Market Size, 2017-2028
        6.5.5 Southeast Asia Diabetic Retinopathy Market Size, 2017-2028
        6.5.6 India Diabetic Retinopathy Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Diabetic Retinopathy Revenue, 2017-2028
        6.6.2 Brazil Diabetic Retinopathy Market Size, 2017-2028
        6.6.3 Argentina Diabetic Retinopathy Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Diabetic Retinopathy Revenue, 2017-2028
        6.7.2 Turkey Diabetic Retinopathy Market Size, 2017-2028
        6.7.3 Israel Diabetic Retinopathy Market Size, 2017-2028
        6.7.4 Saudi Arabia Diabetic Retinopathy Market Size, 2017-2028
        6.7.5 UAE Diabetic Retinopathy Market Size, 2017-2028
7 Players Profiles
    7.1 Bayer
        7.1.1 Bayer Corporate Summary
        7.1.2 Bayer Business Overview
        7.1.3 Bayer Diabetic Retinopathy Major Product Offerings
        7.1.4 Bayer Diabetic Retinopathy Revenue in Global Market (2017-2022)
        7.1.5 Bayer Key News
    7.2 Roche
        7.2.1 Roche Corporate Summary
        7.2.2 Roche Business Overview
        7.2.3 Roche Diabetic Retinopathy Major Product Offerings
        7.2.4 Roche Diabetic Retinopathy Revenue in Global Market (2017-2022)
        7.2.5 Roche Key News
    7.3 Novartis
        7.3.1 Novartis Corporate Summary
        7.3.2 Novartis Business Overview
        7.3.3 Novartis Diabetic Retinopathy Major Product Offerings
        7.3.4 Novartis Diabetic Retinopathy Revenue in Global Market (2017-2022)
        7.3.5 Novartis Key News
    7.4 TEVA
        7.4.1 TEVA Corporate Summary
        7.4.2 TEVA Business Overview
        7.4.3 TEVA Diabetic Retinopathy Major Product Offerings
        7.4.4 TEVA Diabetic Retinopathy Revenue in Global Market (2017-2022)
        7.4.5 TEVA Key News
    7.5 Alimera Sciences
        7.5.1 Alimera Sciences Corporate Summary
        7.5.2 Alimera Sciences Business Overview
        7.5.3 Alimera Sciences Diabetic Retinopathy Major Product Offerings
        7.5.4 Alimera Sciences Diabetic Retinopathy Revenue in Global Market (2017-2022)
        7.5.5 Alimera Sciences Key News
    7.6 Regeneron Pharmaceuticals
        7.6.1 Regeneron Pharmaceuticals Corporate Summary
        7.6.2 Regeneron Pharmaceuticals Business Overview
        7.6.3 Regeneron Pharmaceuticals Diabetic Retinopathy Major Product Offerings
        7.6.4 Regeneron Pharmaceuticals Diabetic Retinopathy Revenue in Global Market (2017-2022)
        7.6.5 Regeneron Pharmaceuticals Key News
    7.7 Boehringer Ingelheim
        7.7.1 Boehringer Ingelheim Corporate Summary
        7.7.2 Boehringer Ingelheim Business Overview
        7.7.3 Boehringer Ingelheim Diabetic Retinopathy Major Product Offerings
        7.7.4 Boehringer Ingelheim Diabetic Retinopathy Revenue in Global Market (2017-2022)
        7.7.5 Boehringer Ingelheim Key News
    7.8 Kowa Group
        7.8.1 Kowa Group Corporate Summary
        7.8.2 Kowa Group Business Overview
        7.8.3 Kowa Group Diabetic Retinopathy Major Product Offerings
        7.8.4 Kowa Group Diabetic Retinopathy Revenue in Global Market (2017-2022)
        7.8.5 Kowa Group Key News
    7.9 Ohr Pharmaceutical
        7.9.1 Ohr Pharmaceutical Corporate Summary
        7.9.2 Ohr Pharmaceutical Business Overview
        7.9.3 Ohr Pharmaceutical Diabetic Retinopathy Major Product Offerings
        7.9.4 Ohr Pharmaceutical Diabetic Retinopathy Revenue in Global Market (2017-2022)
        7.9.5 Ohr Pharmaceutical Key News
    7.10 Quark Pharmaceuticals
        7.10.1 Quark Pharmaceuticals Corporate Summary
        7.10.2 Quark Pharmaceuticals Business Overview
        7.10.3 Quark Pharmaceuticals Diabetic Retinopathy Major Product Offerings
        7.10.4 Quark Pharmaceuticals Diabetic Retinopathy Revenue in Global Market (2017-2022)
        7.10.5 Quark Pharmaceuticals Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
List of Tables
    Table 1. Diabetic Retinopathy Market Opportunities & Trends in Global Market
    Table 2. Diabetic Retinopathy Market Drivers in Global Market
    Table 3. Diabetic Retinopathy Market Restraints in Global Market
    Table 4. Key Players of Diabetic Retinopathy in Global Market
    Table 5. Top Diabetic Retinopathy Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Diabetic Retinopathy Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Diabetic Retinopathy Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Diabetic Retinopathy Product Type
    Table 9. List of Global Tier 1 Diabetic Retinopathy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Diabetic Retinopathy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Diabetic Retinopathy Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Diabetic Retinopathy Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Diabetic Retinopathy Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Diabetic Retinopathy Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Diabetic Retinopathy Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Diabetic Retinopathy Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Diabetic Retinopathy Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Diabetic Retinopathy Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Diabetic Retinopathy Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Diabetic Retinopathy Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Diabetic Retinopathy Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Diabetic Retinopathy Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Diabetic Retinopathy Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Diabetic Retinopathy Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Diabetic Retinopathy Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Diabetic Retinopathy Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Diabetic Retinopathy Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Diabetic Retinopathy Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Diabetic Retinopathy Revenue, (US$, Mn), 2023-2028
    Table 30. Bayer Corporate Summary
    Table 31. Bayer Diabetic Retinopathy Product Offerings
    Table 32. Bayer Diabetic Retinopathy Revenue (US$, Mn), (2017-2022)
    Table 33. Roche Corporate Summary
    Table 34. Roche Diabetic Retinopathy Product Offerings
    Table 35. Roche Diabetic Retinopathy Revenue (US$, Mn), (2017-2022)
    Table 36. Novartis Corporate Summary
    Table 37. Novartis Diabetic Retinopathy Product Offerings
    Table 38. Novartis Diabetic Retinopathy Revenue (US$, Mn), (2017-2022)
    Table 39. TEVA Corporate Summary
    Table 40. TEVA Diabetic Retinopathy Product Offerings
    Table 41. TEVA Diabetic Retinopathy Revenue (US$, Mn), (2017-2022)
    Table 42. Alimera Sciences Corporate Summary
    Table 43. Alimera Sciences Diabetic Retinopathy Product Offerings
    Table 44. Alimera Sciences Diabetic Retinopathy Revenue (US$, Mn), (2017-2022)
    Table 45. Regeneron Pharmaceuticals Corporate Summary
    Table 46. Regeneron Pharmaceuticals Diabetic Retinopathy Product Offerings
    Table 47. Regeneron Pharmaceuticals Diabetic Retinopathy Revenue (US$, Mn), (2017-2022)
    Table 48. Boehringer Ingelheim Corporate Summary
    Table 49. Boehringer Ingelheim Diabetic Retinopathy Product Offerings
    Table 50. Boehringer Ingelheim Diabetic Retinopathy Revenue (US$, Mn), (2017-2022)
    Table 51. Kowa Group Corporate Summary
    Table 52. Kowa Group Diabetic Retinopathy Product Offerings
    Table 53. Kowa Group Diabetic Retinopathy Revenue (US$, Mn), (2017-2022)
    Table 54. Ohr Pharmaceutical Corporate Summary
    Table 55. Ohr Pharmaceutical Diabetic Retinopathy Product Offerings
    Table 56. Ohr Pharmaceutical Diabetic Retinopathy Revenue (US$, Mn), (2017-2022)
    Table 57. Quark Pharmaceuticals Corporate Summary
    Table 58. Quark Pharmaceuticals Diabetic Retinopathy Product Offerings
    Table 59. Quark Pharmaceuticals Diabetic Retinopathy Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Diabetic Retinopathy Segment by Type in 2021
    Figure 2. Diabetic Retinopathy Segment by Application in 2021
    Figure 3. Global Diabetic Retinopathy Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Diabetic Retinopathy Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Diabetic Retinopathy Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Diabetic Retinopathy Revenue in 2021
    Figure 8. By Type - Global Diabetic Retinopathy Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Diabetic Retinopathy Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Diabetic Retinopathy Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Diabetic Retinopathy Revenue Market Share, 2017-2028
    Figure 12. US Diabetic Retinopathy Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Diabetic Retinopathy Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Diabetic Retinopathy Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Diabetic Retinopathy Revenue Market Share, 2017-2028
    Figure 16. Germany Diabetic Retinopathy Revenue, (US$, Mn), 2017-2028
    Figure 17. France Diabetic Retinopathy Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Diabetic Retinopathy Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Diabetic Retinopathy Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Diabetic Retinopathy Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Diabetic Retinopathy Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Diabetic Retinopathy Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Diabetic Retinopathy Revenue Market Share, 2017-2028
    Figure 24. China Diabetic Retinopathy Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Diabetic Retinopathy Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Diabetic Retinopathy Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Diabetic Retinopathy Revenue, (US$, Mn), 2017-2028
    Figure 28. India Diabetic Retinopathy Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Diabetic Retinopathy Revenue Market Share, 2017-2028
    Figure 30. Brazil Diabetic Retinopathy Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Diabetic Retinopathy Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Diabetic Retinopathy Revenue Market Share, 2017-2028
    Figure 33. Turkey Diabetic Retinopathy Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Diabetic Retinopathy Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Diabetic Retinopathy Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Diabetic Retinopathy Revenue, (US$, Mn), 2017-2028
    Figure 37. Bayer Diabetic Retinopathy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Roche Diabetic Retinopathy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Novartis Diabetic Retinopathy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. TEVA Diabetic Retinopathy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Alimera Sciences Diabetic Retinopathy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Regeneron Pharmaceuticals Diabetic Retinopathy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Boehringer Ingelheim Diabetic Retinopathy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Kowa Group Diabetic Retinopathy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Ohr Pharmaceutical Diabetic Retinopathy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Quark Pharmaceuticals Diabetic Retinopathy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
62
Frequently Asked Questions
Diabetic Retinopathy Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Diabetic Retinopathy Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Diabetic Retinopathy Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports